Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Phenotypic and molecular evolution across 10,000 generations in laboratory budding yeast populations.
Hundreds of myosin 10s are pushed to the tips of filopodia and could cause traffic jams on actin.
Classification of infantile seizures: implications for identification and treatment of inborn errors of metabolism.
Iron·ic facts about dementia.
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. N Engl J Med. 2018 02 08; 378(6):518-528.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Bortezomib
Disease-Free Survival
Female
Follow-Up Studies
Humans
Intention to Treat Analysis
Kaplan-Meier Estimate
Male
Melphalan
Middle Aged
Multiple Myeloma
Prednisone
Survival Rate
authors with profiles
Andrzej Jakubowiak